- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03502304
Concurrent Training and Prediabetes Control
May 29, 2018 updated by: Universidad Santo Tomas
Concurrent Training and Prediabetes Comorbidities: An Analysis of Non-responders Using Clinical Cutoff Points
Despite exercise training decrease blood fasting glicaemy in 'average' terms, there is a wide inter-individual variability after exercise training explored mainly in adults but not in adults with prediabetes comorbidities.
Thus, is yet unknown the effects and influence of the concurrent training (CT) eliciting responders (R) and non-responders (NR) cases (i.e., percentage of subjects who experienced a non-change/worsened response after training in some metabolic outcomes).
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
28
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Osorno
-
Los Lagos, Osorno, Chile, 000000000
- Cristian ALvarez
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
30 years to 59 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Written informed consent.
- Interested in improving health and fitness.
Exclusion Criteria:
- Cardiovascular contraindications to exercise,
- History of stroke, asthma or chronic obstructive pulmonary disease,
- Muscle-skeletal disorders, and
- Smoking.
- A compliance rate to the exercise program ≥ 70% was required for the participants in the intervention group to be included in the statistical analyses.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Control group
No-exercise
|
CT in women with prediabetes and co-morbidities associated.
Exercise will be performed at three sessions per week.
Post statistical analyses will be including analyses by the 2 groups proposed.
All sessions will be supervised by an exercise physiologist during 20-weeks.
|
Experimental: Endurance training plus resistant training
To concurrent training (endurance training plus resistant training, RT) program will be use cycle ergometers adapted for obese adults (OXFORDTM, model BE2601, OXOFORD Inc, Santiago, Chile) were used.
Prior to the CT intervention, all subjects were familiarized (during 3 sessions) with the training protocols.
The CT intervention included 3 weekly sessions of both ET and RT.
The core part of each session included RT followed by ET exercises (for 50 and 30 minutes, respectively) and was preceded and followed by a 5-minute warm-up and cool-down with callisthenic movements.
|
CT in women with prediabetes and co-morbidities associated.
Exercise will be performed at three sessions per week.
Post statistical analyses will be including analyses by the 2 groups proposed.
All sessions will be supervised by an exercise physiologist during 20-weeks.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Fasting glucose
Time Frame: Baseline and 20-weeks immediately after the interventions ends
|
Change from Baseline in fasting glucose
|
Baseline and 20-weeks immediately after the interventions ends
|
Lipoproteins
Time Frame: Baseline and 20-weeks immediately after the interventions ends
|
Change from baseline in lipoproteins
|
Baseline and 20-weeks immediately after the interventions ends
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Body mass
Time Frame: Baseline and 20-weeks immediately after the interventions ends
|
Change from Baseline in body mass
|
Baseline and 20-weeks immediately after the interventions ends
|
Waist circumference
Time Frame: Baseline and 20-weeks immediately after the interventions ends
|
Change from Baseline in waist circumference
|
Baseline and 20-weeks immediately after the interventions ends
|
Fat mass
Time Frame: Baseline and 20-weeks immediately after the interventions ends
|
Change from Baseline in fat mass
|
Baseline and 20-weeks immediately after the interventions ends
|
Lean mass
Time Frame: Baseline and 20-weeks immediately after the interventions ends
|
Change from Baseline in lean mass
|
Baseline and 20-weeks immediately after the interventions ends
|
Heart rate at rest
Time Frame: Baseline and 20-weeks immediately after the interventions ends
|
Change from Baseline in heart rate at rest
|
Baseline and 20-weeks immediately after the interventions ends
|
Six minutes walking test
Time Frame: Baseline and 20-weeks immediately after the interventions ends
|
Change from Baseline in six minutes walking test
|
Baseline and 20-weeks immediately after the interventions ends
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Cristian Alvarez, PhD, Universidad de Los Lagos
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 10, 2017
Primary Completion (Actual)
April 9, 2018
Study Completion (Actual)
April 9, 2018
Study Registration Dates
First Submitted
April 9, 2018
First Submitted That Met QC Criteria
April 17, 2018
First Posted (Actual)
April 18, 2018
Study Record Updates
Last Update Posted (Actual)
May 31, 2018
Last Update Submitted That Met QC Criteria
May 29, 2018
Last Verified
May 1, 2018
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 9042018
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Metabolic Disturbance
-
The Swedish School of Sport and Health SciencesActive, not recruiting
-
University of WashingtonNational Heart, Lung, and Blood Institute (NHLBI)Completed
-
Appalachian State UniversityAGRANARecruitingMetabolic Disturbance | Permeability; IncreasedUnited States
-
University of TorontoCanadian Institutes of Health Research (CIHR)RecruitingSedentary Behavior | Metabolic DisturbanceCanada
-
Northumbria UniversityCompletedMetabolic Disturbance | Dietary ExposureUnited Kingdom
-
Appalachian State UniversityRecruitingGastrointestinal Dysfunction | Metabolic DisturbanceUnited States
-
University of TorontoWomen's College HospitalCompleted
-
University of TorontoCompletedMetabolic DisturbanceCanada
-
Northumbria UniversityUnknownMetabolic Disturbance | Dietary ExposureUnited Kingdom
Clinical Trials on Endurance training plus resistant training
-
University of GiessenHannover Medical SchoolUnknownType 2 DiabetesGermany
-
Istituti Clinici Scientifici Maugeri SpAUniversita di VeronaRecruitingChronic Obstructive Pulmonary DiseaseItaly
-
Schön Klinik Berchtesgadener LandCompletedChronic Obstructive Pulmonary DiseaseGermany
-
University Hospital HeidelbergDietmar Hopp Stiftung; Friederike Rosenberger (University Hospital Heidelberg)...Completed
-
University of ViennaCompletedCOVID-19 | Post-COVID-19 Syndrome | Long COVID-19Austria
-
Landsteiner InstitutLund University; Medical University of Vienna; Mein Hanusch-Krankenhaus; Fondazione... and other collaboratorsCompletedType 2 Diabetes Mellitus | Insulin ResistanceAustria
-
Poznan University of Physical EducationPoznan University of Medical Sciences; National Science Centre, PolandActive, not recruitingHealthy Athletes Aged 18-35 YearsPoland
-
Norwegian University of Science and TechnologySt. Olavs HospitalCompletedHyperglycemia | Diabetes Mellitus, Type 2Norway
-
Charite University, Berlin, GermanyUnknownHeart Failure | Sudden Cardiac Death | Cardiac Resynchronisation TherapyGermany